Literature DB >> 29143275

Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.

Mehran B Yusuf1, Mark J Amsbaugh2, Eric Burton3, Megan Nelson4, Brian Williams5, Maria Koutourousiou5, Haring Nauta5, Shiao Woo6.   

Abstract

We sought to determine the impact of time to initiation (TTI) of post-operative radiosurgery on clinical outcomes for patients with resected brain metastases and to identify predictors associated with TTI. All patients with resected brain metastases treated with postoperative SRS or fractionated stereotactic radiation therapy (fSRT) from 2012 to 2016 at a single institution were reviewed. TTI was defined as the interval from resection to first day of radiosurgery. Receiver operating characteristic (ROC) curves were used to identify an optimal threshold for TTI with respect to local failure (LF). Survival outcomes were estimated using the Kaplan-Meier method and analyzed using the log-rank test and Cox proportional hazards models. Logistic regression models were used to identify factors associated with ROC-determined TTI covariates. A total of 79 resected lesions from 73 patients were evaluated. An ROC curve of LF and TTI identified an optimal threshold for TTI of 30.5 days, with an area under the curve of 0.637. TTI > 30 days was associated with an increased hazard of LF (HR 4.525, CI 1.239-16.527) but was not significantly associated with survival (HR 1.002, CI 0.547-1.823) or distant brain failure (DBF, HR 1.943, CI 0.989-3.816). Fifteen patients (20.5%) required post-operative inpatient rehabilitation. Post-operative rehabilitation was associated with TTI > 30 days (OR 1.48, CI 1.142-1.922). In our study of resected brain metastases, longer time to initiation of post-operative radiosurgery was associated with increased local failure. Ideally, post-op SRS should be initiated within 30 days of resection if feasible.

Entities:  

Keywords:  Brain metastases; Fractionated stereotactic radiation therapy; Post-operative radiosurgery; Stereotactic radiosurgery (SRS); Time to initiation

Mesh:

Year:  2017        PMID: 29143275     DOI: 10.1007/s11060-017-2679-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 2.  Response assessment criteria for brain metastases: proposal from the RANO group.

Authors:  Nancy U Lin; Eudocia Q Lee; Hidefumi Aoyama; Igor J Barani; Daniel P Barboriak; Brigitta G Baumert; Martin Bendszus; Paul D Brown; D Ross Camidge; Susan M Chang; Janet Dancey; Elisabeth G E de Vries; Laurie E Gaspar; Gordon J Harris; F Stephen Hodi; Steven N Kalkanis; Mark E Linskey; David R Macdonald; Kim Margolin; Minesh P Mehta; David Schiff; Riccardo Soffietti; John H Suh; Martin J van den Bent; Michael A Vogelbaum; Patrick Y Wen
Journal:  Lancet Oncol       Date:  2015-05-27       Impact factor: 41.316

3.  A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.

Authors:  Cameron Brennan; T Jonathan Yang; Patrick Hilden; Zhigang Zhang; Kelvin Chan; Yoshiya Yamada; Timothy A Chan; Stella C Lymberis; Ashwatha Narayana; Viviane Tabar; Philip H Gutin; Åse Ballangrud; Eric Lis; Kathryn Beal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-01       Impact factor: 7.038

4.  Functional outcomes of persons with brain tumors after inpatient rehabilitation.

Authors:  C M Marciniak; J A Sliwa; A W Heinemann; P E Semik
Journal:  Arch Phys Med Rehabil       Date:  2001-04       Impact factor: 3.966

5.  Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.

Authors:  Leonardo Conrado S Lima; Justin Sharim; Rebecca Levin-Epstein; Stephen Tenn; Alisson R Teles; Tania Kaprealian; Nader Pouratian
Journal:  World Neurosurg       Date:  2016-10-21       Impact factor: 2.104

6.  Inpatient cancer rehabilitation: a retrospective comparison of transfer back to acute care between patients with neoplasm and other rehabilitation patients.

Authors:  Ehsan Alam; Richard D Wilson; Mary M Vargo
Journal:  Arch Phys Med Rehabil       Date:  2008-07       Impact factor: 3.966

Review 7.  The role of radiosurgery to the tumor bed after resection of brain metastases.

Authors:  Jared H Gans; Daniel M S Raper; Ashish H Shah; Amade Bregy; Deborah Heros; Brian E Lally; Jacques J Morcos; Roberto C Heros; Ricardo J Komotar
Journal:  Neurosurgery       Date:  2013-03       Impact factor: 4.654

8.  Tumor bed radiosurgery after resection of cerebral metastases.

Authors:  David Mathieu; Douglas Kondziolka; John C Flickinger; David Fortin; Brendan Kenny; Karine Michaud; Sanjay Mongia; Ajay Niranjan; L Dade Lunsford
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

9.  Functional outcome following rehabilitation of the cancer patient.

Authors:  C M Marciniak; J A Sliwa; G Spill; A W Heinemann; P E Semik
Journal:  Arch Phys Med Rehabil       Date:  1996-01       Impact factor: 3.966

10.  Surgical Cavity Constriction and Local Progression Between Resection and Adjuvant Radiosurgery for Brain Metastases.

Authors:  Jugal K Shah; Matthew B Potts; Penny K Sneed; Manish K Aghi; Michael W McDermott
Journal:  Cureus       Date:  2016-04-19
View more
  10 in total

Review 1.  Brachytherapy for central nervous system tumors.

Authors:  Evan D Bander; Jonathan P S Knisely; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2022-05-11       Impact factor: 4.130

2.  Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies.

Authors:  Kristen Cagino; Ryan Kahn; Susan Pannullo; Hani Ashamalla; Susie Chan; Onyinye Balogun; Charlene Thomas; Paul J Christos; Kevin Holcomb; Melissa K Frey; Eloise Chapman-Davis
Journal:  Gynecol Oncol Rep       Date:  2020-10-31

3.  Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.

Authors:  Cindy Franklin; Peter Mohr; Leonie Bluhm; Imke Grimmelmann; Ralf Gutzmer; Friedegund Meier; Marlene Garzarolli; Michael Weichenthal; Claudia Pfoehler; Rudolf Herbst; Patrick Terheyden; Jochen Utikal; Jens Ulrich; Dirk Debus; Sebastian Haferkamp; Martin Kaatz; Andrea Forschner; Ulrike Leiter; Dorothee Nashan; Alexander Kreuter; Michael Sachse; Julia Welzel; Lucie Heinzerling; Frank Meiss; Carsten Weishaupt; Thilo Gambichler; Gerhard Weyandt; Edgar Dippel; Kerstin Schatton; Eren Celik; Maike Trommer; Iris Helfrich; Alexander Roesch; Lisa Zimmer; Elisabeth Livingstone; Dirk Schadendorf; Susanne Horn; Selma Ugurel
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

4.  Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study.

Authors:  Christopher P Cifarelli; Stefanie Brehmer; John Austin Vargo; Joshua D Hack; Klaus Henning Kahl; Gustavo Sarria-Vargas; Frank A Giordano
Journal:  J Neurooncol       Date:  2019-10-25       Impact factor: 4.130

5.  Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

Authors:  Basem A Dahshan; Joshua S Weir; Robert P Bice; Paul Renz; Daniel T Cifarelli; Linda Poplawski; Joshua Hack; John A Vargo; Christopher P Cifarelli
Journal:  Brachytherapy       Date:  2021-01-14       Impact factor: 2.362

6.  Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.

Authors:  Evan D Bander; Melissa Yuan; Anne S Reiner; Katherine S Panageas; Åse M Ballangrud; Cameron W Brennan; Kathryn Beal; Viviane Tabar; Nelson S Moss
Journal:  Neurooncol Pract       Date:  2021-01-21

Review 7.  The Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review.

Authors:  Melissa Yuan; Eltion Behrami; Susan Pannullo; Theodore H Schwartz; A Gabriella Wernicke
Journal:  Cureus       Date:  2019-09-25

Review 8.  Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.

Authors:  Lei Liu; Wanqi Chen; Ruopeng Zhang; Yuekun Wang; Penghao Liu; Xin Lian; Fuquan Zhang; Yu Wang; Wenbin Ma
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

Review 9.  Current status and recent advances in resection cavity irradiation of brain metastases.

Authors:  Giuseppe Minniti; Maximilian Niyazi; Nicolaus Andratschke; Matthias Guckenberger; Joshua D Palmer; Helen A Shih; Simon S Lo; Scott Soltys; Ivana Russo; Paul D Brown; Claus Belka
Journal:  Radiat Oncol       Date:  2021-04-15       Impact factor: 3.481

10.  Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery.

Authors:  Achiraya Teyateeti; Paul D Brown; Anita Mahajan; Nadia N Laack; Bruce E Pollock
Journal:  Neurooncol Adv       Date:  2021-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.